Medexus Pharmaceuticals Reports Record Revenue of $25.6 Million and $4.2 Million of Adjusted EBITDA* for the Fourth Quarter of Fiscal 2020

Stock Information for Medexus Pharmaceuticals Inc.

Loading

Please wait while we load your information from QuoteMedia.